These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29914653)

  • 1. The potential of imaging tools as correlates of infection and disease for new TB vaccine development.
    Malherbe ST; Kleynhans L; Walzl G
    Semin Immunol; 2018 Oct; 39():73-80. PubMed ID: 29914653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems approaches to correlates of protection and progression to TB disease.
    Fletcher HA
    Semin Immunol; 2018 Oct; 39():81-87. PubMed ID: 30316693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New potential biomarkers to assess efficacy of protection afforded by vaccine candidates against tuberculosis.
    Flores-Valdez MA
    Clin Microbiol Infect; 2019 Jun; 25(6):656-658. PubMed ID: 30797061
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent mouse models and vaccine candidates for preventing chronic/latent tuberculosis infection and its reactivation.
    Pedroza-Roldán C; Flores-Valdez MA
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 29659820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2016 Oct; 84(4):204-10. PubMed ID: 27454335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkey models of tuberculosis: lessons learned.
    Peña JC; Ho WZ
    Infect Immun; 2015 Mar; 83(3):852-62. PubMed ID: 25547788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques.
    Cadena AM; Hopkins FF; Maiello P; Carey AF; Wong EA; Martin CJ; Gideon HP; DiFazio RM; Andersen P; Lin PL; Fortune SM; Flynn JL
    PLoS Pathog; 2018 Oct; 14(10):e1007305. PubMed ID: 30312351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis: current state of knowledge: an epilogue.
    Leung CC; Lange C; Zhang Y
    Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[
    Esmail H; Lai RP; Lesosky M; Wilkinson KA; Graham CM; Coussens AK; Oni T; Warwick JM; Said-Hartley Q; Koegelenberg CF; Walzl G; Flynn JL; Young DB; Barry Iii CE; O'Garra A; Wilkinson RJ
    Nat Med; 2016 Oct; 22(10):1090-1093. PubMed ID: 27595321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - Possible subunit vaccine candidates.
    Santhi D; Raja A
    J Infect; 2016 Nov; 73(5):455-467. PubMed ID: 27404979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation.
    Ma J; Teng X; Wang X; Fan X; Wu Y; Tian M; Zhou Z; Li L
    EBioMedicine; 2017 Aug; 22():143-154. PubMed ID: 28711483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent tuberculosis infection--Revisiting and revising concepts.
    Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
    Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma.
    Locke LW; Kothandaraman S; Tweedle M; Chaney S; Wozniak DJ; Schlesinger LS
    Tuberculosis (Edinb); 2018 Jan; 108():201-210. PubMed ID: 29623875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.
    Mascart F; Locht C
    Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.